Denali Therapeutics
DNLI
Reported
Thursday, February 27
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.91 | -0.67 | 0.24 | 26.37% |
| Revenue | 12.6M | 0.00 | -12.6M | -100.00% |
WhatIF - Earnings
EPS Beat Expectations by $0.24
Denali Therapeutics (DNLI:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything